RGNX
NASDAQ · Biotechnology
Regenxbio Inc
$7.88
-0.46 (-5.52%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+134.5% upside
Low Target
$13.35
Average Target
$18.48
High Target
$24.09
Current Price
$7.88
Current
$7.88
$7.88
Target
$18.48
$18.48
$13.35
$18.48 avg
$24.09
Scenario Analysis
Bear Case
$13.35
69.4%
Low target
Base Case
$18.48
+134.5%
Avg target
Bull Case
$24.09
+205.7%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$16.19
-51.3% from high
52-Week Low
$5.04
+56.5% from low
Target vs 52W High
$18.48
+14.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |